These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8946783)

  • 21. Mechanistic role of calpains in postischemic neurodegeneration.
    Bevers MB; Neumar RW
    J Cereb Blood Flow Metab; 2008 Apr; 28(4):655-73. PubMed ID: 18073773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of calpain proteolysis following traumatic brain injury: implications for pathology and therapy: implications for pathology and therapy: a review and update.
    Kampfl A; Posmantur RM; Zhao X; Schmutzhard E; Clifton GL; Hayes RL
    J Neurotrauma; 1997 Mar; 14(3):121-34. PubMed ID: 9104930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contribution of calpains to myocardial ischaemia/reperfusion injury.
    Inserte J; Hernando V; Garcia-Dorado D
    Cardiovasc Res; 2012 Oct; 96(1):23-31. PubMed ID: 22787134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calpains and neuronal damage in the ischemic brain: The swiss knife in synaptic injury.
    Curcio M; Salazar IL; Mele M; Canzoniero LM; Duarte CB
    Prog Neurobiol; 2016 Aug; 143():1-35. PubMed ID: 27283248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calpain inhibitor A-558693 in experimental focal cerebral ischemia in rats.
    Liebetrau M; Martens H; Thomassen N; Burggraf D; Gabrijelcic-Geiger D; Lubisch W; Möller A; Hamann GF
    Neurol Res; 2005 Jul; 27(5):466-70. PubMed ID: 15978171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gel-based protease proteomics for identifying the novel calpain substrates in dopaminergic neuronal cell.
    Kim C; Yun N; Lee YM; Jeong JY; Baek JY; Song HY; Ju C; Youdim MB; Jin BK; Kim WK; Oh YJ
    J Biol Chem; 2013 Dec; 288(51):36717-32. PubMed ID: 24235151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delayed moderate hypothermia reduces calpain activity and breakdown of its substrate in experimental focal cerebral ischemia in rats.
    Liebetrau M; Burggraf D; Martens HK; Pichler M; Hamann GF
    Neurosci Lett; 2004 Feb; 357(1):17-20. PubMed ID: 15036603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in calcium dynamics following the reversal of the sodium-calcium exchanger have a key role in AMPA receptor-mediated neurodegeneration via calpain activation in hippocampal neurons.
    Araújo IM; Carreira BP; Pereira T; Santos PF; Soulet D; Inácio A; Bahr BA; Carvalho AP; Ambrósio AF; Carvalho CM
    Cell Death Differ; 2007 Sep; 14(9):1635-46. PubMed ID: 17585341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Time-related neuronal changes following middle cerebral artery occlusion: implications for therapeutic intervention and the role of calpain.
    Bartus RT; Dean RL; Cavanaugh K; Eveleth D; Carriero DL; Lynch G
    J Cereb Blood Flow Metab; 1995 Nov; 15(6):969-79. PubMed ID: 7593358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calpain and caspase-3 inhibitors reduce infarct size and post-ischemic apoptosis in rat heart without modifying contractile recovery.
    Perrin C; Ecarnot-Laubriet A; Vergely C; Rochette L
    Cell Mol Biol (Noisy-le-grand); 2003; 49 Online Pub():OL497-505. PubMed ID: 14995081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ca2+-dependent proteases in ischemic neuronal death: a conserved 'calpain-cathepsin cascade' from nematodes to primates.
    Yamashima T
    Cell Calcium; 2004; 36(3-4):285-93. PubMed ID: 15261484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calpain inhibition protects against Taxol-induced sensory neuropathy.
    Wang MS; Davis AA; Culver DG; Wang Q; Powers JC; Glass JD
    Brain; 2004 Mar; 127(Pt 3):671-9. PubMed ID: 14761904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calpain inhibition prevents amyloid-beta-induced neurodegeneration and associated behavioral dysfunction in rats.
    Granic I; Nyakas C; Luiten PG; Eisel UL; Halmy LG; Gross G; Schoemaker H; Möller A; Nimmrich V
    Neuropharmacology; 2010; 59(4-5):334-42. PubMed ID: 20650285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurovascular and neuronal protection by E64d after focal cerebral ischemia in rats.
    Tsubokawa T; Yamaguchi-Okada M; Calvert JW; Solaroglu I; Shimamura N; Yata K; Zhang JH
    J Neurosci Res; 2006 Sep; 84(4):832-40. PubMed ID: 16802320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved posthypoxic recovery of synaptic transmission in gerbil neocortical slices treated with a calpain inhibitor.
    Hiramatsu K; Kassell NF; Lee KS
    Stroke; 1993 Nov; 24(11):1725-8. PubMed ID: 8236348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calpain may contribute to hereditary cataract formation in sheep.
    Robertson LJ; Morton JD; Yamaguchi M; Bickerstaffe R; Shearer TR; Azuma M
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4634-40. PubMed ID: 16303960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Currently evaluated calpain and caspase inhibitors for neuroprotection in experimental brain ischemia.
    Ray SK
    Curr Med Chem; 2006; 13(28):3425-40. PubMed ID: 17168715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calpain-2 as a therapeutic target for acute neuronal injury.
    Wang Y; Bi X; Baudry M
    Expert Opin Ther Targets; 2018 Jan; 22(1):19-29. PubMed ID: 29168923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Processing of cdk5 activator p35 to its truncated form (p25) by calpain in acutely injured neuronal cells.
    Nath R; Davis M; Probert AW; Kupina NC; Ren X; Schielke GP; Wang KK
    Biochem Biophys Res Commun; 2000 Jul; 274(1):16-21. PubMed ID: 10903889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting calpain in synaptic plasticity.
    Baudry M; Chou MM; Bi X
    Expert Opin Ther Targets; 2013 May; 17(5):579-92. PubMed ID: 23379852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.